Title: HER2 overexpression and trastuzumab efficacy in breast cancer

Abstract:
HER2-positive breast cancer patients treated with trastuzumab showed improved survival. Symptoms included breast lump and nipple discharge. Trastuzumab combined with chemotherapy reduced recurrence risk. Cardiac toxicity was a notable side effect.